SB1259 revises the governance structure of the Virginia Commonwealth University Health System Authority. The bill reduces the board of directors from 21 to 17 members and correspondingly lowers the number of appointed members from 19 to 15. It also changes the composition of the appointing authorities, including fewer physician-faculty seats, while preserving representation from the Governor, the Speaker of the House, the Senate Committee on Rules, and the University’s board of visitors. The bill keeps the Authority subject to conflict-of-interest rules and continues to require that appointed members have relevant experience in areas such as business, finance, health care management, commercial real estate, or legal affairs.
The measure also changes board terms and internal governance. Board members would serve four-year terms instead of three-year terms, with revised term-limit rules, and the board would elect its chair and vice-chair every two years rather than annually. The bill maintains the board’s authority to meet, create committees, hire staff and consultants, and adopt bylaws, while clarifying compensation and expense reimbursement provisions. It also updates the voting and fiduciary-duty language for certain members and ex officio participants.
A major substantive change is the restructuring of how the Authority’s chief executive officer is selected and removed. Under the bill, the CEO is no longer simply under board direction; instead, the board and the University’s board of visitors must jointly decide the CEO’s selection, removal, and compensation at a joint meeting. If they cannot agree, each board appoints a three-member committee to resolve the dispute, and if the committees still cannot agree within 30 days, the University president makes the final decision. The bill also requires the CEO to devote full time to the role and clarifies that the current CEO remains in place until a successor is appointed under the new process.
The bill’s impact on state law is limited to the statutes governing the VCU Health System Authority, specifically Code of Virginia §§ 23.1-2402 and 23.1-2403. It changes the Authority’s board size, appointment structure, term lengths, and CEO governance, and it applies the new board-term rules only to appointments made on or after July 1, 2025. In practical terms, the bill shifts more of the Authority’s leadership structure into a joint governance model with the University’s board of visitors and the University president playing a larger role in resolving executive leadership disputes.
The overall sentiment appears strongly favorable and largely noncontroversial. The bill passed the Senate and House overwhelmingly, including unanimous or near-unanimous votes at several stages, and the House amendment was agreed to by the Senate without recorded opposition. The main point of potential contention is the balance of control between the Authority and Virginia Commonwealth University, especially the new joint authority over the CEO and the reduction in board size and physician-faculty representation, but the voting record suggests broad legislative support for the restructuring.
This bill amends the governance statutes for the Virginia Commonwealth University Health System Authority by reducing and rebalancing board membership, extending board terms, changing chair election timing, and revising the process for appointing and removing the Authority’s chief executive officer. It also creates a phased application date for the new term rules and preserves the incumbent CEO until a successor is selected under the new framework. The affected parties are the Authority, Virginia Commonwealth University, the board of visitors, appointing officials, and board members, especially physician-faculty and nonlegislative citizen appointees.
The bill appears to have broad bipartisan and institutional support. It moved through committee and floor votes with overwhelming margins, including unanimous votes at multiple stages and no recorded opposition to the House amendment in the Senate. The absence of committee discussion transcripts limits insight into detailed arguments, but the voting history suggests the restructuring was viewed as a routine or acceptable governance update rather than a controversial policy change.
The main substantive tension is over governance control of the VCU Health System Authority. The bill reduces the board size and the number of physician-faculty seats, which could be seen as decreasing direct clinical representation, while increasing the role of the University’s board of visitors and president in selecting, removing, and setting compensation for the CEO. Any concern would likely come from stakeholders favoring greater Authority independence or stronger physician-faculty influence, but the recorded votes show little visible opposition.